Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 2 drugs with upcoming expirations
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA018967 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA018967 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA018954 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA018954 (NDA)
Xylocaine — XYLOCAINE PRESERVATIVE FREE
Application NDA016801 (NDA)
Xylocaine — XYLOCAINE PRESERVATIVE FREE
Application NDA016801 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA019830 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA019830 (NDA)
Xylocaine — DENTIPATCH
Application NDA020575 (NDA)
Xylocaine — DENTIPATCH
Application NDA020575 (NDA)
Xylocaine — LIDODERM
Application NDA020612 (NDA)
Xylocaine — LIDODERM
Application NDA020612 (NDA)
Xylocaine — ZINGO
Application NDA022114 (NDA)
Xylocaine — ZINGO
Application NDA022114 (NDA)
Xylocaine — AKTEN
Application NDA022221 (NDA)
Xylocaine — AKTEN
Application NDA022221 (NDA)
Xylocaine — ZTLIDO
Application NDA207962 (NDA)
Xylocaine — ZTLIDO
Application NDA207962 (NDA)
Xylocaine — BONDLIDO
Application NDA215029 (NDA)
Xylocaine — BONDLIDO
Application NDA215029 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)